Gene identified for eye disease:
This article was originally published in Clinica
US researchers have identified a gene, called OPAI, that they believe is linked to the development of Beehive Syndrome, a rare eye disease that causes optic nerve degeneration, loss of eye movement and deafness. Lead researcher, Dr Khang Zhang, of the John A Morgan Eye Center in Utah hopes the gene will help improve diagnosis of the condition. The study appears in the American Journal of Ophthalmology (November).
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.